PAVM logo

PAVmed (PAVM)

Profile

Full Name

PAVmed Inc.

Ticker Symbol

PAVM

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

July 27, 2016

Indexes

Not included

Website

http://www.pavmed.com

Employees

39

Key Details

Price

$0.68(-4.90%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$3.00M(+22.15% YoY)

Annual EPS

$0.50(+105.46% YoY)

PE ratio

-

Next earnings date

May 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.68
PAVM price is $0.68

30-Day Relative Volume

0.11
PAVM 30-day relative volume is 0.11

Price Performance

Price Most recent change

-4.9%
PAVM price was down -4.9% on Apr 16, 2025

Price YTD change

+8.28%
PAVM price is up +8.28% since January 1st

Price 1-year change

-65.48%
PAVM price is down -65.48% year-on-year

Price 3-year change

-95.72%
PAVM price is down -95.72% over the past 3 years

Price Range

Price All-time high

$228.60
PAVM price is currently -99.70% below its historical high of $228.60

Price 3-year low

$0.55
PAVM price is currently +23.64% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$11.19M
PAVM market capitalization is $11.19 million

Market cap 3-year change

-87.85%
PAVM market capitalization is down -87.85% over the past 3 years

Market cap All-time high

$795.97M
PAVM market capitalization is currently -98.59% below its historical high of $795.97 million

Market cap sector rank

21.46%
PAVM market capitalization is higher than 21.46% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+85.84%
PAVM shares outstanding is up +85.84% year-on-year

Shares Outstanding 3-Year Change

+184.13%
PAVM shares outstanding is up +184.13% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.73
PAVM beta is 0.73

200-day SMA

$0.89
PAVM price is currently -23.54% below its 200-day simple moving average

50-day SMA

$0.71
PAVM price is currently -4.04% below its 50-day simple moving average

RSI

47.90
PAVM 14-day relative strength index is 47.90

Volume

0.11
PAVM 30-day relative volume is 0.11

ATR

$0.07
PAVM average true range is $0.07

10-day Historical Volatility

105.55%
PAVM 10-day historical volatility is 105.55%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$3.00M
PAVM annual revenue is $3.00 million

Revenue Analysts estimate

$12.73M
PAVM annual revenue is currently -76.48% lower than the consensus analysts' forecast

Revenue 1-year change

+22.15%
PAVM annual revenue is up +22.15% year-on-year

Revenue Sector rank

18.03%
PAVM annual revenue is higher than 18.03% of companies in Healthcare sector

EPS

EPS

$0.50
PAVM annual earnings per share is $0.50

EPS Analysts estimate

-$1.55
PAVM annual earnings per share is currently -132.26% lower than the consensus analysts' forecast

EPS 1-year change

+105.46%
PAVM annual earnings per share is up +105.46% year-on-year

EPS Sector rank

87.11%
PAVM annual earnings per share is higher than 87.11% of companies in Healthcare sector

Profit

Gross profit

-$1.84M
PAVM annual gross profit is -$1.84 million

Gross margin

-61.60%
PAVM annual gross profit margin is -61.60%

Operating profit

-$44.38M
PAVM annual operating income is -$44.38 million

Operating margin

-1481.74%
PAVM annual operating profit margin is -1481.74%

Net income

$39.79M
PAVM annual net profit is $39.79 million

Net margin

-
PAVM annual net profit margin value is unknown

Expenses

Total expenses

$47.37M
PAVM annual total expenses is $47.37 million

Operating expenses

$42.53M
PAVM annual total operating expenses is $42.53 million

Cost of goods sold

$4.84M
PAVM annual cost of goods sold is $4.84 million

Selling, general & administrative expenses

$36.15M
PAVM annual SGA is $36.15 million

Depreciation and amortization

$1.20M
PAVM annual depreciation & amortization is $1.20 million

Interest expense

$45.00K
PAVM annual interest expense is $45.00 thousand

Income tax

$0.00
PAVM annual income tax is $0.00

EBIT & EBITDA

EBIT

$28.47M
PAVM annual earnings before interest & taxes is $28.47 million

EBITDA

$29.67M
PAVM annual EBITDA is $29.67 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$30.66M
PAVM annual total assets is $30.66 million

Non current assets

$28.50M
PAVM annual long term assets is $28.50 million

Current assets

$2.16M
PAVM annual total current assets is $2.16 million

Cash and cash equivalents

$1.19M
PAVM annual cash & cash equivalents is $1.19 million

Accounts receivable

$18.00K
PAVM annual accounts receivable is $18.00 thousand

Inventory

$266.00K
PAVM annual inventory is $266.00 thousand

Liabilities

Total liabilities

$37.69M
PAVM annual total liabilities is $37.69 million

Long term liabilities

$2.25M
PAVM annual total long term liabilities is $2.25 million

Current liabilities

$35.45M
PAVM annual total current liabilities is $35.45 million

Accounts payable

$657.00K
PAVM annual accounts payable is $657.00 thousand

Debt

Total debt

$31.86M
PAVM annual total debt is $31.86 million

Total debt 1-year change

-34.61%
PAVM annual total debt is down -34.61% year-on-year

Long term debt

$2.25M
PAVM annual long term debt is $2.25 million

Short term debt

$29.61M
PAVM annual short term debt is $29.61 million

Equity & Capital

Shareholders equity

-$2.50M
PAVM annual stockholders equity is -$2.50 million

Book value

-$5.81M
PAVM annual book value is -$5.81 million

Retained earnings

-$254.97M
PAVM annual retained earnings is -$254.97 million

Working capital

-$33.28M
PAVM annual working capital is -$33.28 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$33.55M
PAVM annual cash flow from operations is -$33.55 million

Cash from operations 1-year change

+35.52%
PAVM annual cash flow from operations is up +35.52% year-on-year

Cash from investing

-$16.18M
PAVM annual cash flow from investing activities is -$16.18 million

Cash from investing 1-year change

-2235.09%
PAVM annual cash flow from investing activities is down -2235.09% year-on-year

Cash from financing

$31.28M
PAVM annual cash flow from financing activities is $31.28 million

Cash from financing 1-year change

+0.36%
PAVM annual cash flow from financing activities is up +0.36% year-on-year

CAPEX

CAPEX

$55.00K
PAVM annual capital expenditures is $55.00 thousand

CAPEX 1-year change

-77.27%
PAVM annual capital expenditures is down -77.27% year-on-year

Free Cash Flow

Free cash flow

-$33.61M
PAVM annual free cash flow is -$33.61 million

Free cash flow 1-year change

+35.71%
PAVM annual free cash flow is up +35.71% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-61.60%
PAVM annual gross profit margin is -61.60%

Operating margin

-1481.74%
PAVM annual operating profit margin is -1481.74%

Net margin

-
PAVM annual net profit margin value is unknown

ROA & ROE

ROA

124.78%
PAVM annual return on assets is 124.78%

ROE

-1594.83%
PAVM annual return on equity is -1594.83%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
PAVM price to earnings ratio value is unknown

PE ratio Sector rank

-
PAVM price to earnings ratio is unknown

PB Ratio

PB ratio

-1.93
PAVM price to book ratio is -1.93

PB ratio Sector rank

6.34%
PAVM price to book ratio is higher than 6.34% of companies in Healthcare sector

PS Ratio

PS ratio

3.74
PAVM price to sales ratio is 3.74

PS ratio Sector rank

59.36%
PAVM price to sales ratio is higher than 59.36% of companies in Healthcare sector

Enterprise value

Enterprise value

$41.87M
PAVM enterprise value is $41.87 million

Enterprise value Sector rank

39.55%
PAVM enterprise value is higher than 39.55% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

1.41
PAVM EV/EBITDA is 1.41

EV/EBITDA Sector rank

75.39%
PAVM EV/EBITDA is higher than 75.39% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.06
PAVM annual current ratio is 0.06

Quick ratio

0.05
PAVM annual quick ratio is 0.05

Leverage

Debt to equity

-11.66
PAVM annual debt to equity ratio is -11.66

Interest coverage ratio

632.71
PAVM annual interest coverage ratio is 632.71

Risk & Stability

Piotroski F-Score

4
PAVM piotroski f-score is 4

Altman Z-Score

-9.60
PAVM altman z-score is -9.60

Analyst ratings

Recent major analysts updates

Dec 9, 24 Ascendiant Capital
Buy
Aug 18, 23 Cantor Fitzgerald
Neutral
Jan 20, 23 Cantor Fitzgerald
Neutral
Jan 18, 23 Lake Street
Buy
Aug 17, 22 Lake Street
Buy
Mar 30, 21 Cantor Fitzgerald
Overweight
Nov 5, 20 Ascendiant Capital
Buy
Oct 13, 20 Lake Street
Buy
Jun 28, 18 Maxim Group
Buy

Institutional Ownership

Similar stocks

ICU logo
SeaStar Medical Holding (ICU)
PRTG logo
Portage Biotech (PRTG)
Hong Kong Pharma Digital Technology Holdings Limited (HKPD)
PSTV logo
Plus Therapeutics (PSTV)
TXMD logo
TherapeuticsMD (TXMD)
MGRX logo
Mangoceuticals (MGRX)
MRKR logo
Marker Therapeutics (MRKR)
CODX logo
Co-Diagnostics (CODX)
Kairos Pharma (KAPA)
  • What is the ticker symbol for PAVmed?
  • Does PAVmed pay dividends?
  • What sector is PAVmed in?
  • What industry is PAVmed in?
  • What country is PAVmed based in?
  • When did PAVmed go public?
  • Is PAVmed in the S&P 500?
  • Is PAVmed in the NASDAQ 100?
  • Is PAVmed in the Dow Jones?
  • When was PAVmed's last earnings report?
  • When does PAVmed report earnings?
  • Should I buy PAVmed stock now?

What is the ticker symbol for PAVmed?

The ticker symbol for PAVmed is NASDAQ:PAVM

Does PAVmed pay dividends?

No, PAVmed does not pay dividends

What sector is PAVmed in?

PAVmed is in the Healthcare sector

What industry is PAVmed in?

PAVmed is in the Medical Devices industry

What country is PAVmed based in?

PAVmed is headquartered in United States

When did PAVmed go public?

PAVmed's initial public offering (IPO) was on July 27, 2016

Is PAVmed in the S&P 500?

No, PAVmed is not included in the S&P 500 index

Is PAVmed in the NASDAQ 100?

No, PAVmed is not included in the NASDAQ 100 index

Is PAVmed in the Dow Jones?

No, PAVmed is not included in the Dow Jones index

When was PAVmed's last earnings report?

PAVmed's most recent earnings report was on Mar 25, 2025

When does PAVmed report earnings?

The next expected earnings date for PAVmed is May 14, 2025

Should I buy PAVmed stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page